Centene reaffirms 2026 guidance: Centene stock sits 10.79 percent below its high
Published on 10/01/2026 at 07:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Centene Corporation reaffirmed full-year 2026 earnings guidance on September 15, 2026, including GAAP diluted earnings per share above USD 3.11 and adjusted diluted earnings per share above USD 4.80, according to StockTitan. Centene stock sits 10.79 percent below its USD 69.63 52-week high, based on a USD 62.12 reference price and the same quoted range.
Guidance keeps recovery measurable
The guidance floors give investors two distinct earnings benchmarks for fiscal 2026. GAAP diluted earnings per share must exceed USD 3.11, while the adjusted measure must exceed USD 4.80, leaving the non-GAAP figure as the more direct yardstick for operating performance.
The September 15 filing also tied the outlook to management discussions at the Deutsche Bank 2026 Healthcare Summit. That timing matters because the company reaffirmed its outlook after a strong second quarter rather than introducing a new earnings range.
Second-quarter figures show the shift
Centene reported USD 53.579 billion in total revenue for the second quarter of 2026, up from USD 49.944 billion in the first quarter, according to StockTitan. The quarter produced GAAP diluted earnings per share of USD 2.19 and adjusted diluted earnings per share of USD 2.51.
Operating cash flow reached USD 3.590 billion in the second quarter of 2026, while the health benefits ratio improved to 89.6 percent from 93.0 percent in the prior-year quarter. The comparison points to better medical-cost performance, although the guidance floors remain the more relevant forward measure.
Stock remains below yearly high
Centene stock traded at USD 62.12 in the latest finance quote dated September 30, 2026, against a prior close of USD 62.21. Its 52-week range was USD 31.63 to USD 69.63, and market capitalization was USD 30.7 billion as of October 1, 2026.
MarketBeat reported a consensus Hold rating from 21 brokerages and an average 12-month price target of USD 70.05 on September 25, 2026. That target is 12.78 percent above the USD 62.12 reference price, while the stock remains 10.79 percent below its 52-week high.
Centene Corporation stock facts
- Company: Centene Corporation
- Ticker: CNC
- Primary exchange: New York Stock Exchange
- Market capitalization: USD 30.7 billion (as of October 1, 2026)
- 52-week range: USD 31.63-69.63 (as of September 30, 2026)
- Sector / Industry: Healthcare / Healthcare Plans
